Endoglin-Mediated Vascular Remodeling: Mechanisms Underlying Hereditary Hemorrhagic Telangiectasia

Trends in Cardiovascular Medicine

Volumn 18, Issue 1, 2008, Pages 25-32

  Lebrin, Franck ^a   Mummery, Christine L ^b  

^a l'alimentation et l'Environnement   (France)

^b HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; BLOOD VESSEL TONE; ENDOTHELIUM CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RENDU OSLER WEBER DISEASE; REVIEW; VASCULAR SURGERY;

ANIMALS; ANTIGENS, CD; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUSCLE, SMOOTH, VASCULAR; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 38149133230     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.11.003     Document Type: Review

References (89)

1. Abdalla S.A., and Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43 (2006) 97-110
2. Adam P.J., Clesham G.J., and Weissberg P.L. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. Biochem Biophys Res Commun 247 (1998) 33-37
3. Adams R.H., and Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8 (2007) 464-478
4. Arthur H.M., Ure J., Smith A.J., et al. Endoglin, an ancillary TGF-β receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217 (2000) 42-53
5. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
6. Bayrak-Toydemir P., McDonald J., and Akarsu N. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140 (2006) 2155-2162
7. Blanco F.J., Santibanez J.F., Guerrero-Esteo M., et al. Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial TGF-β receptor complex. J Cell Physiol 204 (2005) 574-584
8. Bourdeau A., Dumont D.J., and Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104 (1999) 1343-1351
9. Bourdeau A., Faughnan M.E., and McDonald M.L. Potential role of modifier genes influencing TGF-β1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 158 (2001) 2011-2020
10. Buhring H.J., Muller C.A., Letarte M., et al. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 5 (1991) 841-847
11. Carvalho R.L., Jonker L., Goumans M.J., et al. Defective paracrine signalling by TGF-β in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131 (2004) 6237-6247
12. Carvalho R.L., Itoh F., Goumans M.J., et al. Compensatory mechanisms activated during vasculogenesis in mice by TGF-β receptor deletion. J Cell Science (2007) [in press: 2007]
13. Chen K., Mehta J.L., Li D., et al. TGF-β receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res 95 (2004) 1167-1173
14. Cho S.K., Bourdeau A., Letarte M., et al. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood 98 (2001) 3635-3642
15. Cole S.G., Begbie M.E., Wallace G.M., et al. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42 (2005) 577-582
16. Conley B.A., Smith J.D., Guerrero-Esteo M., et al. Endoglin, a TGF-b receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. Atherosclerosis 153 (2000) 323-335
17. Conley B.A., Koleva R., Smith J.D., et al. Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain. J Biol Chem 279 (2004) 27440-27449
18. David L., Mallet C., Mazerbourg S., et al. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109 (2007) 1953-1961
19. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 (2003) 577-584
20. Duff S.E., Li C., Garland J.M., et al. CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17 (2003) 984-992
21. Feng X.H., and Derynck R. Specificity and versatility in TGF-β signalling through Smads. Annu Rev Cell Dev Biol. 21 (2005) 659-693
22. Fernandez L.A., Sanz-Rodriguez F., Zarrabeitia R., et al. Blood outgrowth endothelial cells from hereditary haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68 (2005) 235-248
23. Fernandez Pujol B., Lucibello F.C., Gehling U.M., et al. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65 (2000) 287-300
24. Fonsatti E., Altomonte M., Nicotra M.R., et al. Endoglin (CD105): a powerful therapeutic target on tumour-associated angiogenetic blood vessels. Oncogene 22 (2003) 6557-6563
25. Fujiyama S., Amano K., Uehira K., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93 (2003) 980-989
26. Gallione C.J., Repetto G.M., Legius E., et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363 (2004) 852-859
27. Gallione C.J., Richards J.A., Letteboer T.G., et al. SMAD4 mutations found in unselected HHT patients. J Med Genet 43 (2006) 793-797
28. Gougos A., and Letarte M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol, 141 (1988) 1925-1933
29. Gougos A., St Jacques S., Greaves A., et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol, 4 (1992) 83-92
30. Goumans M.J., and Mummery C. Functional analysis of the TGF-b receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44 (2000) 253-265
31. Goumans M.J., Valdimarsdottir G., Itoh S., et al. Balancing the activation state of the endothelium via two distinct TGF-b type I receptors. EMBO J 21 (2002) 1743-1753
32. Goumans M.J., Valdimarsdottir G., Itoh S., et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFb/ALK5 signaling. Mol Cell 12 (2003) 817-828
33. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124 (2006) 175-189
34. Guerrero-Esteo M., Sanchez-Elsner T., Letamendia A., et al. Extracellular and cytoplasmic domains of endoglin interact with the TGF-β receptors I and II. J Biol Chem 277 (2002) 29197-29209
35. Guo B., Slevin M., Li C., et al. CD105 inhibits TGF-β-Smad3 signalling. Anticancer Res 24 (2004) 1337-1345
36. Inoue N., Venema R.C., Sayegh H.S., et al. Molecular regulation of the bovine endothelial cell nitric oxide synthase by TGF-β1. Arterioscler Thromb Vasc Biol 15 (1995) 1255-1261
37. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
38. Jerkic M., Rivas-Elena J.V., Prieto M., et al. Endoglin regulates nitric oxide-dependent vasodilatation. Faseb J 18 (2004) 609-611
39. Jerkic M., Rivas-Elena J.V., Santibanez J.F., et al. Endoglin regulates cyclooxygenase-2 expression and activity. Circ Res 99 (2006) 248-256
40. Jerkic M., Rodriguez-Barbero A., Prieto M., et al. Reduced angiogenic responses in adult endoglin heterozygous mice. Cardiovasc Res 69 (2006) 845-854
41. Johnson D.W., Berg J.N., Gallione C.J., et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 5 (1995) 21-28
42. Koleva R.I., Conley B.A., Romero D., et al. Endoglin structure and function: determinants of endoglin phosphorylation by TGF-β receptors. J Biol Chem, 281 (2006) 25110-25123
43. Lamouille S., Mallet C., Feige J.J., et al. Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100 (2002) 4495-4501
44. Lastres P., Letamendia A., Zhang H., et al. Endoglin modulates cellular responses to TGF-b1. J Cell Biol 133 (1996) 1109-1121
45. Lebrin F., Goumans M.J., Jonker L., et al. Endoglin promotes endothelial cell proliferation and TGF-b/ALK1 signal transduction. EMBO J 23 (2004) 4018-4028
46. Lee N.Y., and Blobe G.C. The interaction of endoglin with b-arrestin2 regulates TGF-β-mediated ERK activation and migration in endothelial cells. J Biol Chem 282 (2007) 21507-21517
47. Letamendia A., Lastres P., Botella L.M., et al. Role of endoglin in cellular responses to TGF-β. A comparative study with betaglycan. J Biol Chem 273 (1998) 33011-33019
48. Letarte M., McDonald M.L., Li C., et al. Reduced endothelial secretion and plasma levels of TGF-β1 in patients with hereditary hemorrhagic telangiectasia type 1. Cardiovasc Res 68 (2005) 155-164
49. Li C., Hampson I.N., Hampson L., et al. CD105 antagonizes the inhibitory signalling of TGF-β1 on human vascular endothelial cells. FASEB J 14 (2000) 55-64
50. Li D.Y., Sorensen L.K., Brooke B.S., et al. Defective angiogenesis in mice lacking endoglin. Science 284 (1999) 1534-1537
51. Linder S., and Aepfelbacher M. Podosomes: adhesion hot-spots of invasive cells. Trends Cell Biol 13 (2003) 376-385
52. Llorca O., Trujillo A., Blanco F.J., et al. Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol 365 (2007) 694-705
53. Lux A., Salway F., Dressman H.K., et al. ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-b and constitutively active receptor induced gene expression. BMC Cardiovasc Disord 6 (2006) 13
54. Ma X., Labinaz M., Goldstein J., et al. Endoglin is overexpressed after arterial injury and is required for TGF-β-induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vasc Biol 20 (2000) 2546-2552
55. Mancini M.L., Verdi J.M., Conley B.A., et al. Endoglin is required for myogenic differentiation potential of neural crest stem cells. Dev Biol 308 (2007) 520-533
56. Massague J., Seoane J., and Wotton D. Smad transcription factors. Genes Dev 19 (2005) 2783-2810
57. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-b binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8 (1994) 345-351
58. Moreau V., Tatin F., Varon C., et al. Actin can reorganize into podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA. Mol Cell Biol 23 (2003) 6809-6822
59. Obreo J., Diez-Marques L., Lamas S., et al. Endoglin expression regulates basal and TGF-β-induced extracellular matrix synthesis in cultured L6E9 myoblasts. Cell Physiol Biochem 14 (2004) 301-310
60. Oh S.P., Seki T., Goss K.A., et al. Activin receptor-like kinase 1 modulates TGF-β1 signalling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97 (2000) 2626-2631
61. Ota T., Fujii M., Sugizaki T., et al. Targets of transcriptional regulation by two distinct type I receptors for TGF-β in human umbilical vein endothelial cells. J Cell Physiol 193 (2002) 299-318
62. Paquet M.E., Pece-Barbara N., Vera S., et al. Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 10 (2001) 1347-1357
63. Park C., Lavine K., Mishina Y., et al. Bone morphogenetic protein receptor 1A signalling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 133 (2006) 3473-3484
64. Pece N., Vera S., Cymerman U., et al. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 100 (1997) 2568-2579
65. Pece-Barbara N., Cymerman U., Vera S., et al. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet 8 (1999) 2171-2181
66. Pece-Barbara N., Vera S., Kathirkamathamby K., et al. Endoglin null endothelial cells proliferate faster and are more responsive to TGF-β1 with higher affinity receptors and an activated Alk1 pathway. J Biol Chem 280 (2005) 27800-27808
67. Pepper M.S. TGF-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8 (1997) 21-43
68. Pérez-Gómez E., Elino N., Lopez-Nóvoa J.M., et al. Characterization of murine S-endoglin isoform and its effects on tumor development. Oncogene 24 (2005) 4450-4461
69. Perlingeiro R.C. Endoglin is required for hemangioblast and early hematopoietic development. Development 134 (2007) 3041-3048
70. Pierelli L., Bonanno G., Rutelli S., et al. CD105 (endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymphoma 42 (2001) 1195-1206
71. Rehman J., Li J., Orschell C.M., et al. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
72. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
73. Robledo M.M., Hidalgo A., Lastres P., et al. Characterization of TGF-b 1-binding proteins in human bone marrow stromal cells. Br J Haematol 93 (1996) 507-514
74. Rodriguez-Barbero A., Obreo J., Alvarez-Munoz P., et al. Endoglin modulation of TGF-b1-induced collagen synthesis is dependent on ERK1/2 MAPK activation. Cell Physiol Biochem 18 (2006) 135-142
75. Rokhlin O.W., Cohen M.B., Kubagawa H., et al. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J Immunol 154 (1995) 4456-4465
76. Sanz-Rodriguez F., Guerrero-Esteo M., Botella L.M., et al. Endoglin regulates cytoskeletal organization through binding to ZRP-1, a member of the Lim family of proteins. J Biol Chem 279 (2004) 32858-32868
77. Saura M., Zaragoza C., Cao W., et al. Smad2 mediates TGF-β induction of endothelial nitric oxide synthase expression. Circ Res 91 (2002) 806-813
78. Scharpfenecker M., van Dinther M., Liu Z., et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120 (2007) 964-972
79. Seki T., Hong K.H., and Oh S.P. Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development. Lab Invest 86 (2006) 116-129
80. She X., Matsuno F., Harada N., et al. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-β in suppression of growth of human endothelial cells. Int J Cancer 108 (2004) 251-257
81. Shi Y., and Massague J. Mechanisms of TGF-β signalling from cell membrane to the nucleus. Cell 113 (2003) 685-700
82. Srinivasan S., Hanes M.A., Dickens T., et al. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12 (2003) 473-482
83. Toporsian M., Gros R., Kabir M.G., et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 96 (2005) 684-692
84. Torsney E., Charlton R., Diamond A.G., et al. Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 107 (2003) 1653-1657
85. Van den Driesche S., Mummery C.L., and Westermann C.J. Hereditary hemorrhagic telangiectasia: an update on TGF-β signalling in vasculogenesis and angiogenesis. Cardiovasc Res 58 (2003) 20-31
86. Van Laake L.W., van den Driesche S., Post S., et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 114 (2006) 2288-2297
87. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
88. Wu X., Ma J., Han J.D., et al. Distinct regulation of gene expression in human endothelial cells by TGF-b and its receptors. Microvasc Res 71 (2006) 12-19
89. Xu B., Wu Y.Q., Huey M., et al. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain. J Cereb Blood Flow Metab 24 (2004) 237-244